These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 18307529)

  • 1. Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.
    Herbert C; Hettiaratchi A; Webb DC; Thomas PS; Foster PS; Kumar RK
    Clin Exp Allergy; 2008 May; 38(5):847-56. PubMed ID: 18307529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthma.
    Kumar RK; Herbert C; Thomas PS; Wollin L; Beume R; Yang M; Webb DC; Foster PS
    J Pharmacol Exp Ther; 2003 Oct; 307(1):349-55. PubMed ID: 12954795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
    Karish SB; Gagnon JM
    Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    van Schalkwyk E; Strydom K; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbröker D; Bardin PG
    J Allergy Clin Immunol; 2005 Aug; 116(2):292-8. PubMed ID: 16083782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phosphodiesterase activity, airway inflammation and hyperresponsiveness by PDE4 inhibitor and glucocorticoid in a murine model of allergic asthma.
    Sun JG; Deng YM; Wu X; Tang HF; Deng JF; Chen JQ; Yang SY; Xie QM
    Life Sci; 2006 Oct; 79(22):2077-85. PubMed ID: 16875702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the phosphodiesterase type 4 inhibitor roflumilast on early and late allergic response and airway hyperresponsiveness in Aspergillus-fumigatus-sensitized mice.
    Hoymann HG; Wollin L; Muller M; Korolewitz R; Krug N; Braun A; Beume R
    Pharmacology; 2009; 83(3):188-95. PubMed ID: 19176983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin-17F in a mouse model of allergic asthma.
    Suzuki S; Kokubu F; Kawaguchi M; Homma T; Odaka M; Watanabe S; Ieki K; Matsukura S; Kurokawa M; Takeuchi H; Sasaki Y; Huang SK; Adachi M; Ota H
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():89-94. PubMed ID: 17541285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
    Bundschuh DS; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
    J Pharmacol Exp Ther; 2001 Apr; 297(1):280-90. PubMed ID: 11259555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
    Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
    Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of roflumilast in the treatment of asthma.
    Bateman ED; Izquierdo JL; Harnest U; Hofbauer P; Magyar P; Schmid-Wirlitsch C; Leichtl S; Bredenbröker D
    Ann Allergy Asthma Immunol; 2006 May; 96(5):679-86. PubMed ID: 16729780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of roflumilast on airway remodelling in a murine model of chronic asthma.
    Kim SW; Kim JH; Park CK; Kim TJ; Lee SY; Kim YK; Kwon SS; Rhee CK; Yoon HK
    Clin Exp Allergy; 2016 May; 46(5):754-63. PubMed ID: 26542330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effect of the antiasthma Chinese herbal formula MSSM-002 on TH2 cells.
    Srivastava K; Teper AA; Zhang TF; Li S; Walsh MJ; Huang CK; Kattan M; Schofield BH; Sampson HA; Li XM
    J Allergy Clin Immunol; 2004 Feb; 113(2):268-76. PubMed ID: 14767441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Oryza sativa extract on the progression of airway inflammation and remodeling in an experimental animal model of asthma.
    Lee SH; Choi SM; Sohn YS; Kang KK; Yoo M
    Planta Med; 2006 Apr; 72(5):405-10. PubMed ID: 16557453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase type 4 inhibitors cause proinflammatory effects in vivo.
    McCluskie K; Klein U; Linnevers C; Ji YH; Yang A; Husfeld C; Thomas GR
    J Pharmacol Exp Ther; 2006 Oct; 319(1):468-76. PubMed ID: 16861399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma.
    Olmez D; Babayigit A; Uzuner N; Erbil G; Karaman O; Yilmaz O; Cetin EO; Ozogul C
    Exp Lung Res; 2008 Oct; 34(8):501-11. PubMed ID: 18850376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roflumilast Altana Pharma.
    Reid P
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1165-70. PubMed ID: 12211409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curative effects of phosphodiesterase 4 inhibitors cilomilast, roflumilast, and rolipram in dermatitis mouse model.
    Harada D; Ikeda Y; Nosaka Y; Kobayashi K; Manabe H
    J Dermatol Sci; 2008 Sep; 51(3):215-9. PubMed ID: 18539440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.